http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2533063-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048 |
| filingDate | 2011-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1587176c842f346fcdb10c856e049df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_539da1888cdd66b0107c53a383fcfa6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571a56049700f9445fe2bc753adf02d4 |
| publicationDate | 2015-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2533063-T3 |
| titleOfInvention | New ringed pyridine compounds |
| abstract | A compound of the formula (I) ** Formula ** in which: X is O or S; Y is -C (O) - or -S (O) 2-; A is a single or double bond, provided that if X is S, then A is a double bond; R 1 is hydrogen, C 1-7 alkyl, C 1-7 haloalkyl, C 2-7 alkenyl, C 2-7 alkynyl, cycloalkyl, heterocycloalkyl, aryl, aryl fused with heterocycloalkyl, heteroaryl or -N (R 6) 2; said C1-7 alkyl, C1-7 haloalkyl, C2-7 alkenyl and C2-7 alkynyl are optionally substituted one to three times by independent R4; and said cycloalkyl, heterocycloalkyl, aryl, aryl fused with heterocycloalkyl and heteroaryl are optionally substituted one to three times by independent R5; R2, R3 are independently hydrogen, halogen, C1-7 alkyl, C1-7 haloalkyl, hydroxy, C1-7 alkoxy or C1-7 haloalkoxy; R4 is cyano, cycloalkyl, heterocycloalkyl, aryl, aryl fused with heterocycloalkyl, heteroaryl, -C (O) N (R6) 2, - N (R6) 2, -NH (CO) -C1-7 alkyl, hydroxy, C1 alkoxy -7, C1-7 haloalkoxy, oxo or -S (O) 2R7, said cycloalkyl, heterocycloalkyl, aryl, aryl fused with heterocycloalkyl and heteroaryl are optionally substituted one to three times by independent R5; R5 is halogen, cyano, C1-7 alkyl, C1-7 haloalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, -C (O) N (R6) 2, - N (R6) 2, -NH (CO) -C1 alkyl -7, hydroxy, C1-7 alkoxy, C1-7 haloalkoxy, oxo or -S (O) 2R7, said cycloalkyl, heterocycloalkyl, aryl and heteroaryl are optionally substituted one to three times by substituents independently selected from the group formed by halogen, cyano, C1-7 alkyl, C1-7 haloalkyl, hydroxy, alkoxy and oxo; R6 is hydrogen or C1-7 alkyl; R7 is hydrogen, C1-7 alkyl or aryl, said aryl is optionally substituted one to three times by substituents independently selected from the group consisting of halogen, cyano, C1-7 alkyl, C1-7 haloalkyl, hydroxy, C1- alkoxy 7, C1-7 haloalkoxy; and its pharmaceutically acceptable salts and esters; wherein the term "cycloalkyl" denotes a monovalent saturated monocyclic or bicyclic hydrocarbon radical of 3 to 8 ring atoms; wherein the term "heterocycloalkyl" denotes a monovalent saturated or partially unsaturated monovalent mono- or bicyclic ring system of 4 to 9 carbon atoms, comprising 1, 2 or 3 ring heteroatoms chosen from N, O and S, the atoms being ring remaining carbon; wherein the term "aryl" denotes a monovalent aromatic mono- or bicyclic ring system comprising 6 to 10 carbon ring atoms; and wherein the term "heteroaryl" denotes a monovalent aromatic mono- or bicyclic heterocyclic ring system of 5 to 12 ring atoms, comprising 1, 2, 3 or 4 heteroatoms chosen from N, O and S, the atoms being remaining carbon ring. |
| priorityDate | 2010-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 381.